0 results for 'Sanofi SA'
Bristol-Myers Pleads Guilty in Plavix Antitrust Probe, to Pay $1 Million Fine
Bristol-Myers Squibb said it pleaded guilty to two counts of making false statements to the FTC and will pay a fine of $1 million. The company acknowledged that an unnamed "former senior executive" led Apotex to believe that Bristol-Myers would not launch a competing generic version of blood thinner Plavix if Apotex agreed to a settlement, and implied that then-chief executive Pete Dolan shared his views. In September, Bristol-Myers pushed out Dolan and said GC Richard K. Willard would leave the company.Federal Advisers Recommend Restricting Use of Controversial Antibiotic
Federal health advisers say the benefits of the antibiotic Ketek, which has been linked to reports of liver problems and several deaths, outweigh its risks in treating pneumonia, but not less severe infections like bronchitis and sinusitis. The advisers' review raises the possibility that the FDA will disapprove the drug for treatment of the lesser infections. A Senate committee is investigating the FDA's handling of Ketek, and one senator has accused the agency of withholding information on the drug.Applications for jobless benefits rise to 462K
More people applied for unemployment benefits last week, the first rise in three weeks and evidence that companies are reluctant to hire in a slow economy.Bristol-Myers Squibb sees 3Q profit dip 2 percent
Bristol-Myers Squibb Co. posted a slight decline in third-quarter profit Tuesday as its restrained spending was offset by flat sales of its drugs, lower income from its partners and bigger discounts to government because of the health care overhaul.Buyers Find Hope in Vitamin Case
The justices declared that foreign plaintiffs cannot sue in U.S. courts for antitrust violations outside the United States-but left open one line of argument that could make potential plaintiffs happy.FDA Gives Antibiotic New Scrutiny After Reports of Fatalities
The antibiotic Ketek, linked to reports of severe liver problems, including several deaths, will be subjected to new scrutiny by U.S. health advisers, according to a federal notice. Meanwhile, the Senate Finance Committee is investigating allegations of fraud connected with trials of Ketek, or telithromycin, as well as how the FDA has handled relevant safety issues. Through April, the FDA received at least a dozen reports of acute liver failure, including four deaths, among patients treated with Ketek.Trending Stories
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250
Strong & Hanni Solves Storage Woes--Learn How You Can, Too
Brought to you by Filevine
Download Now
Meeting the Requirements of California's SB 553: Workplace Violence Prevention
Brought to you by NAVEX Global
Download Now
The Benefits of Outsourcing Beneficial Ownership Information Filing
Brought to you by Wolters Kluwer
Download Now
The Top 10 AI Use Cases in Private Equity
Brought to you by Ontra
Download Now